Samsung BioLogics' Revised Valuation Based on P/B Multiple
In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...
347 Views
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
357 Views
4 Main Issues at Samsung Electronics EGM on Oct 27
What can we really expect from Samsung Electronics' extraordinary general meeting scheduled for Thursday (Oct 27) this week?SEC's EGM...
254 Views
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
348 Views
Why Some Believe Samsung Restructuring Will Happen Earlier
Why do some people believe that Samsung restructuring will take place much earlier than widely expected? These people believe Samsung will make an...
355 Views